Back to search

Peptide record

TPDB20425

Antibacterial Anticancer Hemolysis Toxicity standard
15 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB20425
Antibacterial Anticancer Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia PD_Hemolysis
standard
No
A 15-aa standard natural multi-activity (Antibacterial, Anticancer, Hemolysis, and other sources) peptide sequence curated from Peptipedia and PD_Hemolysis, with an available 3D structural model.
Sequence
GLRKRLRKFFNKIKF
Physicochemical Analysis
C93H155N29O17
ADCEQHMPSTWYV
K
1951.44
12.72
7
0
6
+7
2.00
-0.833
78.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
1
Residue Composition
number
0
A
3
R
1
N
0
D
0
C
0
E
0
Q
1
G
0
H
1
I
2
L
4
K
0
M
3
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 3 N: 1 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 1 L: 2 K: 4 M: 0 F: 3 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
15
C93H155N29O17
1951.44
12.72
+7
2.00
-0.833
Evidence Records 6 records
Evidence 1 Activity

Activity

12% Hemolysis
Toxicity
40 µM
Hemolytic Cytotoxic
12% Hemolysis | 40 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity. | Biochem J | 2021
Evidence 2 Activity

Activity

27% Killing
Toxicity
40 µM
Cytotoxic
27% Killing | 40 | µM | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity. | Biochem J | 2021
Evidence 3 Activity

Activity

50% Hemolysis
Toxicity
471.41 µM
Hemolytic Cytotoxic
50% Hemolysis | 471.41 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Development of novel broad-spectrum amphipathic antimicrobial peptides against multidrug-resistant bacteria through a rational combination strategy | J Adv Res | 2025
Evidence 4 Activity

Activity

50% Cytotoxicity
Toxicity
351.6 µM
Cytotoxic
50% Cytotoxicity | 351.6 | µM | target cell: Human embryonic kidney HEK293T cells

Target

Human embryonic kidney HEK293T cells

Source & Reference

NA
DBAASP
Development of novel broad-spectrum amphipathic antimicrobial peptides against multidrug-resistant bacteria through a rational combination strategy | J Adv Res | 2025
Evidence 5 Activity

Activity

% Hemolysis
Toxicity
10 %
Hemolytic Cytotoxic
Hemolytic_activity: Human erythrocytes: <10% Hemolysis =40 µM | Cytotoxicity: HEK293: 20% Killing=40 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochem J. 2021 Jan 15 478(1):63-78.
Evidence 6 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis